reveal

Light-Activated Cancer Drugs with Chemistry's Phoebe Glazer

At the University of Kentucky, Assistant Professor of Chemistry Edith "Phoebe" Glazer is looking for something more effective at killing cancer cells and less toxic to healthy cells than cisplatin. A platinum-based drug, cisplatin is one of the most commonly used cancer drugs, but leads to nausea and nerve damage. Her alternative uses ruthenium, another transition metal, to build complex molecules. Theses molecules can be "switched on" by light from a fiber-optic probe once they reach their target tumor and would kill only cancerous cells. In January 2013, Glazer received a four-year, $715,000 grant from the American Cancer Society to develop a family of ruthenium molecules to fight different kinds of cancer.

This video appears courtesy of Reveal: University of Kentucky Research Media research.uky.edu/reveal/

UK Researchers Speak Out: Sequester Will Squelch Scientists-in-Training

“From the standpoint of training the next generation of highly skilled professors, industrial scientists, people to work in government laboratories, people to advance our understanding of disease and advance the next generation of therapies, it will be profoundly devastating for this generation of students.”
Subscribe to RSS - reveal
X
Enter your linkblue username.
Enter your linkblue password.
Secure Login

This login is SSL protected

Loading